How do you pay?

How to pay the least

Ask for the cash price

Generic everolimus

No pharmacy we check posts a price for it.

  1. Ask your pharmacy for the cash price of generic everolimus.Find pharmacies near you 
  2. Ask one or two other pharmacies too. Cash prices for the same generic can differ a lot from store to store.

A regular generic has the same active ingredient as Afinitor Disperz, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameAfinitor Disperz
Authorized genericeverolimus
Regular genericeverolimus
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
Cash priceAsk the pharmacyUsually the lowest
Same as Afinitor Disperz?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

Novartis Oncology Universal Co-pay Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $15,000 a year off your co-pay.

Sign up on afinitor-hcp.com 

Or call 1-800-282-7630.

In the maker’s words

“Eligible patients with private insurance may pay $0 per month…”

From the maker’s offer on afinitor-hcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Afinitor Disperz itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericMakers and their savings cards

3 companies sell a generic of Afinitor Disperz that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 2 of them have their own savings cards, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.

  • Amneal PharmaceuticalsAll 3 strengths

    Has lactose

    Amneal Everolimus Tablets for Oral Suspension Copay Card

    With commercial insurance as little as $0 a month

    Sign up on amneal.com

    In the maker’s words

    “Eligible, commercially insured patients may receive their Amneal Everolimus Tablets for Oral Suspension monthly prescription for $0.”

    Product page on amneal.com

    How it looks, what’s in it, NDCs

    2 mg White to off-white, round, 9 mm, marked “A62”

    PackageNDC
    Carton of 2860219-2279-2

    3 mg White to off-white, round, 10 mm, marked “A63”

    PackageNDC
    Carton of 2860219-2280-2

    5 mg White to off-white, round, 12 mm, marked “A65”

    PackageNDC
    Carton of 2860219-2281-2

    Inactive ingredients: crospovidone (120 .mu.m), hypromellose 2208 (3 mpa.s), lactose monohydrate, magnesium stearate, mannitol, microcrystalline cellulose 112, silicon dioxide

    FDA label

  • Breckenridge PharmaceuticalAll 3 strengths

    Has lactose · Made by Natco Pharma

    Everolimus Tablets for Oral Suspension (Everolimus TFOS) Savings Program

    With commercial insurance as little as $0

    Sign up on everolimustabletsfororalsuspension.copaysavingsprogram.com

    Or call 1-877-340-2833.

    In the maker’s words

    “Under the program, qualifying patients may pay as little as $0 out of pocket per prescription.”

    Product page on breckenridgepharma.com

    How it looks, what’s in it, NDCs

    2 mg White, round, 9 mm, marked “E / 2”

    PackageNDC
    Carton of 2851991-990-28
    Bottle of 2851991-990-77

    3 mg White, round, 10 mm, marked “E / 3”

    PackageNDC
    Carton of 2851991-991-28
    Bottle of 2851991-991-77

    5 mg White, round, 12 mm, marked “E / 5”

    PackageNDC
    Carton of 2851991-992-28
    Bottle of 2851991-992-77

    Inactive ingredients: butylated hydroxytoluene, hypromellose 2910 (3 mpa.s), anhydrous lactose, acetone, crospovidone (120 .mu.m), microcrystalline cellulose, mannitol, silicon dioxide, magnesium stearate

    FDA label

  • Biocon PharmaAll 3 strengths
    How it looks, what’s in it, NDCs

    2 mg White to off white, round, 9 mm, marked “E2”

    PackageNDC
    Bottle of 2870377-090-11
    Carton of 2870377-090-23

    3 mg White to off white colored, round, 10 mm, marked “E3”

    PackageNDC
    Bottle of 2870377-091-11
    Carton of 2870377-091-23

    5 mg White to off white colored, round, 11 mm

    PackageNDC
    Bottle of 2870377-092-11
    Carton of 2870377-092-23

    Inactive ingredients: butylated hydroxytoluene, crospovidone, hypromellose 2910 (3 mpa.s), magnesium stearate, mannitol, microcrystalline cellulose

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

What to say at the pharmacy

“Before you fill my Afinitor Disperz, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

AFINITOR is a kinase inhibitor indicated for the treatment of:

  • Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
  • Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. Limitations of Use: AFINITOR is not indicated for the treatment of patients with functional carcinoid tumors.
  • Adults with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib.
  • Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery.

AFINITOR and AFINITOR DISPERZ are kinase inhibitors indicated for the treatment of adult and pediatric patients aged 1 year and older with TSC who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.

AFINITOR DISPERZ is a kinase inhibitor indicated for the adjunctive treatment of adult and pediatric patients aged 2 years and older with TSC-associated partial-onset seizures.

Source: the FDA label for Afinitor Disperz (Novartis Pharmaceuticals Corporation), June 1, 2026. Full label on DailyMed 

Good to know